Abnormal Uterine Bleeding in Premenopausal Women

被引:17
|
作者
Wouk, Noah [1 ]
Helton, Margaret [2 ]
机构
[1] Piedmont Hlth Serv, 322 Main St, Prospect Hill, NC 27314 USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
关键词
LEVONORGESTREL INTRAUTERINE SYSTEM; QUALITY-OF-LIFE; MEDROXYPROGESTERONE ACETATE; ENDOMETRIAL POLYPS; DISORDERS; MENORRHAGIA; MANAGEMENT; PREVALENCE; DIAGNOSIS; MENSTRUATION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Abnormal uterine bleeding is a common symptom in women. The acronym PALM-COEIN facilitates classification, with PALM referring to structural etiologies (polyp, adenomyosis, leiomyoma, malignancy and hyperplasia), and COEIN referring to nonstructural etiologies (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not otherwise classified). Evaluation involves a detailed history and pelvic examination, as well as laboratory testing that includes a pregnancy test and complete blood count. Endometrial sampling should be performed in patients 45 years and older, and in younger patients with a significant history of unopposed estrogen exposure. Transvaginal ultrasonography is the preferred imaging modality and is indicated if a structural etiology is suspected or if symptoms persist despite appropriate initial treatment. Medical and surgical treatment options are available. Emergency interventions for severe bleeding that causes hemodynamic instability include uterine tamponade, intravenous estrogen, dilation and curettage, and uterine artery embolization. To avoid surgical risks and preserve fertility, medical management is the preferred initial approach for hemodynamically stable patients. Patients with severe bleeding can be treated initially with oral estrogen, high-dose estrogen-progestin oral contraceptives, oral progestins, or intravenous tranexamic acid. The most effective long-term medical treatment for heavy menstrual bleeding is the levonorgestrel-releasing intrauterine system. Other long-term medical treatment options include estrogen-progestin oral contraceptives, oral progestins, oral tranexamic acid, nonsteroidal anti-inflammatory drugs, and depot medroxyprogesterone. Hysterectomy is the definitive treatment. A tower-risk surgical option is endometrial ablation, which performs as well as the levonorgestrel-releasing intrauterine system. Select patients with chronic uterine bleeding can be treated with myomectomy, polypectomy, or uterine artery embolization. Copyright (C) 2019 American Academy of Family Physicians.
引用
收藏
页码:435 / 443
页数:9
相关论文
共 50 条
  • [21] Abnormal Uterine Bleeding in Women with Infertility
    Caitlin R. Sacha
    Irene Souter
    Current Obstetrics and Gynecology Reports, 2017, 6 (1) : 42 - 50
  • [22] Abnormal Uterine Bleeding in Adolescent Women
    Mullins E.S.
    Miller R.J.
    Mullins T.L.K.
    Current Pediatrics Reports, 2018, 6 (2) : 123 - 131
  • [23] DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
    Zhao, Xingping
    Yang, Yanfei
    Fu, Yinqin
    Lv, Weigang
    Xu, Dabao
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (08) : 1165 - 1171
  • [24] Response to Mahajan et al.:: Endometrial thickness screening in premenopausal women with abnormal uterine bleeding
    Getpook, Chatpavit
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2007, 33 (06) : 887 - 887
  • [25] 2020 Hong Kong College of Obstetricians and Gynaecologists guideline on investigations of premenopausal women with abnormal uterine bleeding
    Lee, Jacqueline H. S.
    Cheng, Edith O. L.
    Choi, K. M.
    Ngu, S. F.
    Cheung, Rachel Y. K.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (06) : 520 - 525
  • [26] Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy
    Maas, Angela H. E. M.
    von Euler, Mia
    Bongers, Marlies Y.
    Rolden, Herbert J. A.
    Grutters, Janneke P. C.
    Ulrich, Lian
    Schenck-Gustafsson, Karin
    MATURITAS, 2015, 82 (04) : 355 - 359
  • [27] Histopathological Findings of Uterine Sample in Women with Abnormal Uterine Bleeding
    Al Kinani, Marwa Jamal Hussain
    Fahad, Iqbal Abed
    Maslat, Abeer Hussein
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E155 - E160
  • [28] Risk factors for atypical hyperplasia or endometrial cancer in premenopausal women aged ≤ 45 years with abnormal uterine bleeding
    Jang, Shina
    Hwang, Sung-Ook
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 302 : 288 - 293
  • [29] Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding (vol 2019, 8598152, 2019)
    Giannella, Luca
    Cerami, Lillo Bruno
    Setti, Tiziano
    Bergamini, Ezio
    Boselli, Fausto
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [30] THE MANAGEMENT OF ABNORMAL PREMENOPAUSAL BLEEDING
    HUFFMAN, JW
    SURGICAL CLINICS OF NORTH AMERICA, 1953, 33 (01) : 183 - 192